<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04683471</url>
  </required_header>
  <id_info>
    <org_study_id>EXA-2001</org_study_id>
    <nct_id>NCT04683471</nct_id>
  </id_info>
  <brief_title>Pilot Trial of a System for Motor Function Recovery</brief_title>
  <official_title>Pilot Feasibility Clinical Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Niche Biomedical Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Niche Biomedical Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, prospective, blinded, pilot feasibility study to evaluate improvement&#xD;
      in sensory and motor function with sham.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)</measure>
    <time_frame>Biweekly through study completion up to 18 weeks</time_frame>
    <description>Change in Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) for the upper limbs&#xD;
Scoring:&#xD;
Strength scored 0 - 50 for each arm&#xD;
Sensibility scored 0 - 24 for each arm&#xD;
Prehension scored 0 - 42 for each arm&#xD;
Higher scores are a better outcome</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Spinal Cord Diseases</condition>
  <arm_group>
    <arm_group_label>Neuromodulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neuromodulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stimulator</intervention_name>
    <description>Neuromodulation</description>
    <arm_group_label>Neuromodulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>Sham</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Traumatic chronic spinal cord injury&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active implanted medical device&#xD;
&#xD;
          -  Internal metallic objects of unknown or foreign origin&#xD;
&#xD;
          -  Implanted anti-spasticity pumps, Botox injections in prior 3 months or other current&#xD;
             anti-spasticity regimen&#xD;
&#xD;
          -  BMI &gt; 40.0&#xD;
&#xD;
          -  Acute medical conditions under active treatment that would contraindicate standard&#xD;
             rehabilitation including open wounds&#xD;
&#xD;
          -  Pregnancy or planned pregnancy&#xD;
&#xD;
          -  Unhealed bone fractures, peripheral neuropathies or painful musculoskeletal&#xD;
             dysfunction&#xD;
&#xD;
          -  Cardiopulmonary disease or ventilator dependency&#xD;
&#xD;
          -  Uncontrolled epilepsy or seizures&#xD;
&#xD;
          -  Clinically significant depression, psychiatric disorders or ongoing substance abuse&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>R. Yung</last_name>
    <phone>(424) 256-2194</phone>
    <email>contactus@nichebio.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shirley Ryan AbilityLab</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kennedy Krieger Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Research Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 15, 2020</study_first_submitted>
  <study_first_submitted_qc>December 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2020</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

